Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 2
This trial was for people with non small cell lung cancer (NSCLC) that had either:
grown into the surrounding tissues (locally advanced)
spread to other parts of the body (advanced)
It was for people who had certain proteins (receptors) called PD-L1 on the surface of their cancer cells. This is called PD-L1 positive.
Recruitment start: 17 July 2014
Recruitment end: 4 December 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Schmid
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Roche Products Limited
Last reviewed: 23 Jul 2018
CRUK internal database number: 12217
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
